vs
MYOMO, INC.（MYO）与Rent the Runway, Inc.（RENT）财务数据对比。点击上方公司名可切换其他公司
MYOMO, INC.的季度营收约是Rent the Runway, Inc.的1.1倍（$11.4M vs $10.6M），Rent the Runway, Inc.净利率更高（721.7% vs -33.6%，领先755.3%），Rent the Runway, Inc.同比增速更快（10.4% vs -5.9%），过去两年MYOMO, INC.的营收复合增速更高（73.9% vs 1.0%）
MYOMO INC.是一家医疗科技企业，研发和生产可穿戴肌电矫形设备，帮助上肢瘫痪或无力的患者恢复肢体活动能力，核心产品面向中风、脊髓损伤及其他神经系统疾病患者，主要市场覆盖北美地区。
Rent the Runway Inc.是总部位于纽约的美国电商平台，由珍妮弗·海曼与珍妮弗·弗莱斯于2009年11月创立，主打设计师品牌服饰与配饰的租赁、订阅以及购买服务，是设计师服饰共享租赁模式的开创平台之一。
MYO vs RENT — 直观对比
营收规模更大
MYO
是对方的1.1倍
$10.6M
营收增速更快
RENT
高出16.3%
-5.9%
净利率更高
RENT
高出755.3%
-33.6%
两年增速更快
MYO
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $11.4M | $10.6M |
| 净利润 | $-3.8M | $76.5M |
| 毛利率 | 68.6% | -126.4% |
| 营业利润率 | -24.4% | -152.8% |
| 净利率 | -33.6% | 721.7% |
| 营收同比 | -5.9% | 10.4% |
| 净利润同比 | -1366.4% | 504.8% |
| 每股收益（稀释后） | $-0.09 | $13.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MYORENT
| Q4 25 | $11.4M | $10.6M | ||
| Q3 25 | $10.1M | $11.7M | ||
| Q2 25 | $9.7M | $7.6M | ||
| Q1 25 | $9.8M | $11.8M | ||
| Q4 24 | $12.1M | $9.6M | ||
| Q3 24 | $9.2M | $10.4M | ||
| Q2 24 | $7.5M | $8.9M | ||
| Q1 24 | $3.8M | $10.4M |
净利润MYORENT
| Q4 25 | $-3.8M | $76.5M | ||
| Q3 25 | $-3.7M | $-26.4M | ||
| Q2 25 | $-4.6M | $-26.1M | ||
| Q1 25 | $-3.5M | $-13.4M | ||
| Q4 24 | $-260.1K | $-18.9M | ||
| Q3 24 | $-966.4K | $-15.6M | ||
| Q2 24 | $-1.1M | $-22.0M | ||
| Q1 24 | $-3.8M | $-24.8M |
毛利率MYORENT
| Q4 25 | 68.6% | -126.4% | ||
| Q3 25 | 63.8% | -92.3% | ||
| Q2 25 | 62.7% | -168.4% | ||
| Q1 25 | 67.2% | -71.2% | ||
| Q4 24 | 71.4% | -122.9% | ||
| Q3 24 | 75.4% | -98.1% | ||
| Q2 24 | 70.8% | -131.5% | ||
| Q1 24 | 61.2% | -93.3% |
营业利润率MYORENT
| Q4 25 | -24.4% | -152.8% | ||
| Q3 25 | -34.9% | -171.8% | ||
| Q2 25 | -47.6% | -259.2% | ||
| Q1 25 | -35.8% | -65.3% | ||
| Q4 24 | -2.0% | -142.7% | ||
| Q3 24 | -10.4% | -92.3% | ||
| Q2 24 | -14.8% | -185.4% | ||
| Q1 24 | -103.6% | -185.6% |
净利率MYORENT
| Q4 25 | -33.6% | 721.7% | ||
| Q3 25 | -36.3% | -225.6% | ||
| Q2 25 | -48.0% | -343.4% | ||
| Q1 25 | -35.2% | -113.6% | ||
| Q4 24 | -2.2% | -196.9% | ||
| Q3 24 | -10.5% | -150.0% | ||
| Q2 24 | -14.9% | -247.2% | ||
| Q1 24 | -102.2% | -238.5% |
每股收益（稀释后）MYORENT
| Q4 25 | $-0.09 | $13.65 | ||
| Q3 25 | $-0.09 | $-6.55 | ||
| Q2 25 | $-0.11 | $-6.58 | ||
| Q1 25 | $-0.08 | $-2.72 | ||
| Q4 24 | $0.00 | $-4.70 | ||
| Q3 24 | $-0.03 | $-4.17 | ||
| Q2 24 | $-0.03 | $-6.03 | ||
| Q1 24 | $-0.10 | $-5.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.4M | $50.7M |
| 总债务越低越好 | $11.2M | — |
| 股东权益账面价值 | $11.4M | $-35.1M |
| 总资产 | $38.6M | $231.0M |
| 负债/权益比越低杠杆越低 | 0.98× | — |
8季度趋势，按日历期对齐
现金及短期投资MYORENT
| Q4 25 | $18.4M | $50.7M | ||
| Q3 25 | $12.6M | $43.6M | ||
| Q2 25 | $15.5M | $70.4M | ||
| Q1 25 | $21.5M | $77.4M | ||
| Q4 24 | $24.9M | $74.1M | ||
| Q3 24 | $6.6M | $76.6M | ||
| Q2 24 | $9.0M | $82.0M | ||
| Q1 24 | $11.0M | $84.0M |
总债务MYORENT
| Q4 25 | $11.2M | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $1.3M | $340.6M | ||
| Q1 25 | — | $333.7M | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MYORENT
| Q4 25 | $11.4M | $-35.1M | ||
| Q3 25 | $14.6M | $-232.1M | ||
| Q2 25 | $17.6M | $-207.1M | ||
| Q1 25 | $21.7M | $-182.5M | ||
| Q4 24 | $24.7M | $-171.2M | ||
| Q3 24 | $9.3M | $-154.5M | ||
| Q2 24 | $9.7M | $-141.3M | ||
| Q1 24 | $10.9M | $-122.3M |
总资产MYORENT
| Q4 25 | $38.6M | $231.0M | ||
| Q3 25 | $34.1M | $219.0M | ||
| Q2 25 | $38.7M | $245.3M | ||
| Q1 25 | $40.9M | $240.0M | ||
| Q4 24 | $42.2M | $251.6M | ||
| Q3 24 | $16.3M | $257.4M | ||
| Q2 24 | $16.2M | $278.4M | ||
| Q1 24 | $16.5M | $278.5M |
负债/权益比MYORENT
| Q4 25 | 0.98× | — | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.1M | $-1.4M |
| 自由现金流经营现金流 - 资本支出 | $-2.4M | — |
| 自由现金流率自由现金流/营收 | -21.0% | — |
| 资本支出强度资本支出/营收 | 10.9% | — |
| 现金转化率经营现金流/净利润 | — | -0.02× |
| 过去12个月自由现金流最近4个季度 | $-18.7M | — |
8季度趋势，按日历期对齐
经营现金流MYORENT
| Q4 25 | $-1.1M | $-1.4M | ||
| Q3 25 | $-1.8M | $-10.5M | ||
| Q2 25 | $-8.9M | $8.3M | ||
| Q1 25 | $-2.7M | $1.4M | ||
| Q4 24 | $3.4M | $4.7M | ||
| Q3 24 | $-1.5M | $2.2M | ||
| Q2 24 | $-1.9M | $4.6M | ||
| Q1 24 | $-3.2M | $-8.0M |
自由现金流MYORENT
| Q4 25 | $-2.4M | — | ||
| Q3 25 | $-2.9M | — | ||
| Q2 25 | $-10.1M | — | ||
| Q1 25 | $-3.3M | — | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | $-1.8M | — | ||
| Q2 24 | $-2.0M | — | ||
| Q1 24 | $-3.3M | — |
自由现金流率MYORENT
| Q4 25 | -21.0% | — | ||
| Q3 25 | -28.6% | — | ||
| Q2 25 | -104.9% | — | ||
| Q1 25 | -34.0% | — | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | -19.7% | — | ||
| Q2 24 | -27.1% | — | ||
| Q1 24 | -88.0% | — |
资本支出强度MYORENT
| Q4 25 | 10.9% | — | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 13.0% | — | ||
| Q1 25 | 6.8% | — | ||
| Q4 24 | 7.1% | — | ||
| Q3 24 | 3.5% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 1.6% | — |
现金转化率MYORENT
| Q4 25 | — | -0.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MYO
| Direct To Patient | $7.9M | 69% |
| Clinical And Medical Providers | $3.5M | 31% |
RENT
暂无分部数据
